William Grossman M.D.

William Grossman MD, PhD, is an accomplished medical professional with extensive experience in the biotechnology and pharmaceutical sectors. William serves on the Board of Directors for Day One Biopharmaceuticals and BryoLogyx while contributing to Ginkgo Bioworks, Inc. as an Advisory Board Member. As the founder of Grossman Biotech & Pharma Consulting, LLC, William leverages expertise in oncology, previously holding the position of Senior Vice President of Oncology Clinical Development and Therapeutic Area Head at Gilead Sciences. William's educational background includes an MD and PhD from Washington University School of Medicine in St. Louis, complemented by clinical experience at St. Louis Children's Hospital.